PPARGC1A and cardiovascular disorder: The results showed TFDM was the main active ingredient in DML and could exert therapeutic effects on cardiovascular diseases through the NOX-4/ROS/p38 MAPK, Bcl-2/Bax and AMPK/SIRT1/PGC-1α signalling pathways.